Clinical trial
Modafinil to Reduce Persistent Fatigue in Patients Following Treatment for…
NCT00178373 · University of Rochester, Other · Completed
Key facts
| NCT number | NCT00178373 |
|---|---|
| Title | Modafinil to Reduce Persistent Fatigue in Patients Following Treatment for Cancer |
| Official title | Modafinil to Reduce Persistent Fatigue in Patients Following Treatment for Cancer |
| Lead sponsor | University of Rochester, Other |
| Collaborators | Cephalon Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cancer, Fatigue, Chemotherapy |
| Intervention type | Drug |
| Interventions | Modafinil, sugar pill |
| Enrollment | 96 |
| Start date | May 1, 2004 |
| Primary completion | Dec 1, 2005 |
| Completion | Mar 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Dec 23, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: